Dr. Samuel Lance, MD

Dr. Lance practices at Baylor Scott & White Continuing Care Hospital - Temple in Temple, Texas.

Dr. Lance's NPI, 1780811786, was assigned on June 17, 2009. Dr. Lance graduated from McGovern Medical School in 2009. Dr. Lance's Texas license number on file is T9161.

Dr. Lance's primary practice is Baylor Scott & White Continuing Care Hospital - Temple, at 2401 South 31st St, Temple, TX 76504 in Bell County. The practice phone is (254) 771-8200.

Dr. Lance's primary practice is Baylor Scott & White Continuing Care Hospital - Temple in Temple, Texas. Dr. Lance is also affiliated with Baylor Scott & White Medical Center - Temple. The medical group on file is Baylor Scott & White Temple Roney Bone and Joint Institute, Temple. Dmand AI also links Dr. Lance to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lance practices, 4 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Lance's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Lance is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Lance's licenses on file in 2 states: Texas and California.

Dmand AI lists breast surgery and cancerous skin growth removal among the conditions Dr. Lance treats.

CMS data shows 17 Medicare services from Dr. Lance across 1 procedure code in 2019, all of them office visits, for 33 Medicare patients. Medicare paid $723 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 33 Medicare patients who saw Dr. Lance in 2024. The largest group is 65 to 74, with 14 patients. 75% of them have high cholesterol, and 67% have arthritis. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lance's median patient age at 57, with 61% women.

In 2024, Dr. Lance wrote 60 Medicare Part D claims for 28 patients. 98% of them were for generic drugs. CMS names the drug for 27 of them, across 2 drugs with 11 or more claims each, at $126 in total drug cost. In 2023, CMS named 54 claims across 3 drugs.

Dr. Lance accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 35 papers to Dr. Lance, published from 2010 to 2024. 2023 was the busiest year, with 3. The most frequent topics are Craniosynostoses, Osteogenesis, Distraction and Skull. Dr. Lance has published most often in Ann Plast Surg. Dr. Lance's most frequent co-authors are Amanda Anderson Gosman, MD, Michael Gregory Brandel, MD and Asra Hashmi, MBBS.

CMS Open Payments shows 46 general payments to Dr. Lance from 19 drug and device companies from 2016 to 2025. Gifts make up the largest share, 59% of the total. 3D Systems paid the most, $3,717.

Dr. Lance graduated from McGovern Medical School in 2009.

Dr. Lance is in network with 17 carriers, including Aetna, United Healthcare and Elevance. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.